Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 34

1.

Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant.

Zur D, Iglicki M, Sala-Puigdollers A, Chhablani J, Lupidi M, Fraser-Bell S, Mendes TS, Chaikitmongkol V, Cebeci Z, Dollberg D, Busch C, Invernizzi A, Habot-Wilner Z, Loewenstein A; International Retina Group (IRG).

Acta Ophthalmol. 2019 Aug 17. doi: 10.1111/aos.14230. [Epub ahead of print]

PMID:
31421028
2.

One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation.

Singh SR, Fung AT, Fraser-Bell S, Lupidi M, Mohan S, Gabrielle PH, Zur D, Iglicki M, M López-Corell P, Gallego-Pinazo R, Farinha C, Lima LH, Mansour AM, Casella AM, Wu L, Silva R, Uwaydat SH, Govindahari V, Arevalo JF, Chhablani J.

Br J Ophthalmol. 2019 Aug 10. pii: bjophthalmol-2019-314542. doi: 10.1136/bjophthalmol-2019-314542. [Epub ahead of print]

PMID:
31401554
3.

Outer retinal hyperreflective deposits (ORYD): a new OCT feature in naïve diabetic macular oedema after PPV with ILM peeling.

Iglicki M, Loewenstein A, Barak A, Schwartz S, Zur D.

Br J Ophthalmol. 2019 Aug 7. pii: bjophthalmol-2019-314523. doi: 10.1136/bjophthalmol-2019-314523. [Epub ahead of print]

PMID:
31391181
4.

Filigree Vascular Pattern in Combined Hamartoma of Retina and Retinal Pigment Epithelium on OCT Angiography.

Gupta R, Pappuru RR, Fung KAT, Lupidi M, Kaliki S, Yannuzzi L, Freund KB, Reid K, Zur D, Iglicki M, Chhablani J.

Ophthalmol Retina. 2019 Apr 29. pii: S2468-6530(19)30164-2. doi: 10.1016/j.oret.2019.04.024. [Epub ahead of print]

PMID:
31229419
5.

TRActional DIabetic reTInal detachment surgery with co-adjuvant intravitreal dexamethasONe implant: the TRADITION STUDY.

Iglicki M, Zur D, Fung A, Gabrielle PH, Lupidi M, Santos R, Busch C, Rehak M, Cebeci Z, Charles M, Masarwa D, Schwarz S, Barak A, Loewenstein A; International Retina Group (IRG).

Acta Diabetol. 2019 May 14. doi: 10.1007/s00592-019-01357-y. [Epub ahead of print]

PMID:
31089929
6.

The Role of Steroids in the Management of Diabetic Macular Edema.

Zur D, Iglicki M, Loewenstein A.

Ophthalmic Res. 2019 May 2:1-6. doi: 10.1159/000499540. [Epub ahead of print] Review.

7.

Safety of 6000 intravitreal dexamethasone implants.

Rajesh B, Zarranz-Ventura J, Fung AT, Busch C, Sahoo NK, Rodriguez-Valdes PJ, Sarao V, Mishra SK, Saatci AO, Udaondo Mirete P, Querques G, Farah ME, Lanzetta P, Arevalo JF, Kodjikian L, Chhablani J; International Ozurdex Study Group.

Br J Ophthalmol. 2019 Apr 30. pii: bjophthalmol-2019-313991. doi: 10.1136/bjophthalmol-2019-313991. [Epub ahead of print]

PMID:
31040132
8.

Real-world outcomes of observation and treatment in diabetic macular edema with very good visual acuity: the OBTAIN study.

Busch C, Fraser-Bell S, Zur D, Rodríguez-Valdés PJ, Cebeci Z, Lupidi M, Fung AT, Gabrielle PH, Giancipoli E, Chaikitmongkol V, Okada M, Laíns I, Santos AR, Kunavisarut P, Sala-Puigdollers A, Chhablani J, Ozimek M, Hilely A, Unterlauft JD, Loewenstein A, Iglicki M, Rehak M; International Retina Group.

Acta Diabetol. 2019 Jul;56(7):777-784. doi: 10.1007/s00592-019-01310-z. Epub 2019 Mar 22.

9.

Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter Study.

Busch C, Iglicki M, Okada M, Gabrielle PH, Cohen S, Mariussi M, Amphornphruet A, Cebeci Z, Chaikitmongkol V, Couturier A, Fraser-Bell S, Fung AT, Iannetta D, Radecka L, Laíns I, Rodrigues TM, Lupidi M, Ozimek M, Sala-Puigdollers A, Rehak M, Loewenstein A, Zur D; for the International Retina Group (IRG).

Ophthalmologica. 2019;241(4):211-219. doi: 10.1159/000496942. Epub 2019 Mar 19.

PMID:
30889590
10.

Aminobisphosphonate-associated orbital and ocular inflammatory disease.

Keren S, Leibovitch I, Ben Cnaan R, Neudorfer M, Fogel O, Greenman Y, Shulman S, Zur D, Habot-Wilner Z.

Acta Ophthalmol. 2019 Aug;97(5):e792-e799. doi: 10.1111/aos.14063. Epub 2019 Feb 28.

PMID:
30816018
11.
12.

Subretinal Fluid Optical Density and Spectral-Domain Optical Coherence Tomography Characteristics for the Diagnosis of Circumscribed Choroidal Hemangioma.

Zur D, Frenkel S, Leshno A, Iglicki M, Ben-Artzi Cohen N, Khoury A, Martínez Cartier M, Barak A, Moroz I, Loewenstein A, Neudorfer M, Vishnevskia-Dai V.

Ophthalmologica. 2019;241(4):195-201. doi: 10.1159/000492948. Epub 2018 Nov 5.

PMID:
30396183
13.

Disorganization of Retinal Inner Layers as a Biomarker for Idiopathic Epiretinal Membrane After Macular Surgery-The DREAM Study.

Zur D, Iglicki M, Feldinger L, Schwartz S, Goldstein M, Loewenstein A, Barak A.

Am J Ophthalmol. 2018 Dec;196:129-135. doi: 10.1016/j.ajo.2018.08.037. Epub 2018 Sep 1.

PMID:
30179599
14.

Reply.

Zur D, Iglicki M, Busch C, Lupidi M, Loewenstein A.

Ophthalmology. 2018 Sep;125(9):e61-e62. doi: 10.1016/j.ophtha.2018.03.025. Epub 2018 Aug 21. No abstract available.

PMID:
30143101
15.

UNDERDIAGNOSED OPTIC DISK PIT MACULOPATHY: Spectral Domain Optical Coherence Tomography Features For Accurate Diagnosis.

Iglicki M, Busch C, Loewenstein A, Fung AT, Invernizzi A, Mariussi M, Arias R, Gabrielle PH, Cebeci Z, Okada M, Nawrocki J, Michalewska Z, Goldstein M, Barak A, Zur D.

Retina. 2018 Jul 24. doi: 10.1097/IAE.0000000000002270. [Epub ahead of print]

PMID:
30045135
16.

Biomarkers and predictors for functional and anatomic outcomes for small gauge pars plana vitrectomy and peeling of the internal limiting membrane in naïve diabetic macular edema: The VITAL Study.

Iglicki M, Lavaque A, Ozimek M, Negri HP, Okada M, Chhablani J, Busch C, Loewenstein A, Zur D.

PLoS One. 2018 Jul 11;13(7):e0200365. doi: 10.1371/journal.pone.0200365. eCollection 2018.

17.

Long-term visual outcome and its predictors in macular oedema secondary to retinal vein occlusion treated with dexamethasone implant.

Busch C, Rehak M, Sarvariya C, Zur D, Iglicki M, Lima LH, Invernizzi A, Viola F, Agrawal K, Sinawat S, Couturier A, Mehta A, Juneja R, Jain H, Agarwal AK, Goel N, Nagpal M, Gupta V, Banker A, Loewenstein A, Okada M, Saatci AO, Mansour AM, Chhablani J.

Br J Ophthalmol. 2019 Apr;103(4):463-468. doi: 10.1136/bjophthalmol-2017-311805. Epub 2018 Jun 11.

PMID:
29891733
18.

Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema.

Busch C, Zur D, Fraser-Bell S, Laíns I, Santos AR, Lupidi M, Cagini C, Gabrielle PH, Couturier A, Mané-Tauty V, Giancipoli E, Ricci GD, Cebeci Z, Rodríguez-Valdés PJ, Chaikitmongkol V, Amphornphruet A, Hindi I, Agrawal K, Chhablani J, Loewenstein A, Iglicki M, Rehak M; International Retina Group.

Acta Diabetol. 2018 Aug;55(8):789-796. doi: 10.1007/s00592-018-1151-x. Epub 2018 May 5.

PMID:
29730822
19.

DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study.

Iglicki M, Busch C, Zur D, Okada M, Mariussi M, Chhablani JK, Cebeci Z, Fraser-Bell S, Chaikitmongkol V, Couturier A, Giancipoli E, Lupidi M, Rodríguez-Valdés PJ, Rehak M, Fung AT, Goldstein M, Loewenstein A.

Retina. 2019 Jan;39(1):44-51. doi: 10.1097/IAE.0000000000002196.

PMID:
29697589
20.

Prevalence of choroidal nevus and retinal pigment epithelial alterations in vitiligo patients.

Fleissig E, Pavlovksy M, Loewenstein A, Zur D, Newman H, Keren S, Goldenberg D, Bar-Ilan E, Goldstein M.

Graefes Arch Clin Exp Ophthalmol. 2018 May;256(5):927-933. doi: 10.1007/s00417-018-3958-0. Epub 2018 Mar 16.

PMID:
29549426

Supplemental Content

Loading ...
Support Center